Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Elevated plasma cotinine is associated with an increased risk of developing IBD, especially among users of combusted tobacco
Umeå universitet, Medicinska fakulteten, Institutionen för medicinsk biovetenskap, Klinisk kemi.ORCID-id: 0000-0003-0787-3368
Umeå universitet, Medicinska fakulteten, Institutionen för farmakologi och klinisk neurovetenskap.
Vise andre og tillknytning
2020 (engelsk)Inngår i: PLOS ONE, E-ISSN 1932-6203, Vol. 15, nr 7, artikkel-id e0235536Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Objective: Smoking has previously been associated with inflammatory bowel disease (IBD), but no study has reported on cotinine, an objective, biochemical measure of tobacco use. We aimed at testing the hypothesis that cotinine levels among healthy subjects are associated with an increased risk of developing IBD in later life.

Design: We analysed plasma cotinine and evaluated corresponding lifestyle questionnaires that included tobacco habits in subjects (n = 96) who later developed late-onset IBD (70 ulcerative colitis (UC) and 26 Crohn’s disease (CD)) and in sex and age-matched controls (n = 191).

Results: Patients who later developed IBD had significantly higher plasma cotinine levels compared to controls. In multivariable analysis, higher log-cotinine was associated with a higher risk of developing IBD (OR 1.34 (95% CI 1.01–1.63)). After stratifying for time to diagnosis, the association was only significant in subjects with shorter time (< 5.1 years) to diagnosis (OR 1.45 (1.09–1.92)). The findings were similar for UC- and CD-cases, but did not reach statistical significance in CD-cases. Although plasma cotinine concentrations were higher in snuff users compared to combusted tobacco users, no increase in the risk of IBD and lower risk of developing IBD among subjects with shorter time (< 5.1 years) to diagnosis was seen among snuff users.

Conclusions: Cotinine, a biomarker of tobacco use, is associated with increased risk of developing late-onset IBD in general, and UC in particular. No increased risk among snuff users indicates that other components in combusted tobacco than nicotine may be involved in the pathogenesis of IBD among smokers.

sted, utgiver, år, opplag, sider
Public Library of Science (PLOS) , 2020. Vol. 15, nr 7, artikkel-id e0235536
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-173880DOI: 10.1371/journal.pone.0235536ISI: 000549913100038PubMedID: 32614903Scopus ID: 2-s2.0-85087472900OAI: oai:DiVA.org:umu-173880DiVA, id: diva2:1456754
Forskningsfinansiär
Region Västerbotten, VLL-678111Region Västerbotten, VLL-582981Swedish Research Council, VR 2017-00650Tilgjengelig fra: 2020-08-06 Laget: 2020-08-06 Sist oppdatert: 2025-02-11bibliografisk kontrollert
Inngår i avhandling
1. Lifestyle, biomarkers and the risk of developing inflammatory bowel disease
Åpne denne publikasjonen i ny fane eller vindu >>Lifestyle, biomarkers and the risk of developing inflammatory bowel disease
2023 (engelsk)Doktoravhandling, med artikler (Annet vitenskapelig)
Alternativ tittel[sv]
Livsstil, biomarkörer och risken att utveckla inflammatorisk tarmsjukdom
Abstract [en]

Introduction: Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic disease causing inflammation in the gut mucosa. The pathogenesis involves alteration in gut microbiota and in the intestinal barrier due to genetic factors, environmental exposure and dysregulation of the immune response. Several environmental risk factors and risk genes have been identified, but still, the pathogenesis is not fully understood. 

Methods: Included papers are all case-control studies based on previously collected data stored with the biobank in Umeå, Sweden. Cases are individuals that participated in the Northern Sweden Health and Disease Study (NSHDS) at least one year before developing IBD. Information was available for all cases regarding age, time and place for inclusion in NSHDS, height and weight, sex and tobacco use. Part of the cases also had available data from a detailed food-frequency questionnaire. For each available case, controls matched for age, sex and time and place were selected. Analysed factors included tobacco use, with smoking and snuff use analysed separately), cotinine (a metabolite of nicotine), iron status (including ferritin, iron, transferrin and transferrin saturation), B-vitamins and tryptophan metabolites. 

Results: Smoking was associated with an increased risk of developing IBD both based on questionnaire data and using cotinine as a marker for exposure. Snuff use was not associated with risk for developing IBD. A lower ferritin was associated with an increased risk of developing IBD, whereas no association was seen for other iron status analytes. When analysing iron deficiency based on ferritin and CRP, it was shown that iron deficiency was more common among men before onset of IBD, whereas no difference was seen for women. Active vitamin B6 was lower among cases compared to controls, as well as an index indicating functional B6 deficiency. Kynurenic acid and xanthurenic acid, both tryptophan metabolites with immunomodulatory properties, were lower among cases than controls. For CD only, picolinic acid was lower among cases later developing IBD.

Discussion: Smoking increases the risk of developing both UC and CD. Snuff use did not increase the risk for IBD, indicating that tobacco exposure is not the reason for increased IBD risk. Low ferritin indicates an early pathological process affecting iron storage unrelated to inflammation. Changes in vitamin B6 and tryptophan metabolites might indicate early pathological processes possibly related to gut microbiota changes. 

To conclude, this dissertation shows that multiple differences between individuals later developing IBD and controls can be seen years before IBD diagnosis. Some of which give insight to early pathophysiology in IBD.

sted, utgiver, år, opplag, sider
Umeå: Umeå University, 2023. s. 86
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2247
Emneord
Inflammatory bowel disease, ulcerative colitis, Crohn's disease, smoking, cotinine, iron deficiency, ferritin, pyridoxal-5-phosphate, kynurenine pathway
HSV kategori
Forskningsprogram
klinisk kemi; invärtesmedicin
Identifikatorer
urn:nbn:se:umu:diva-208115 (URN)978-91-8070-035-1 (ISBN)978-91-8070-034-4 (ISBN)
Disputas
2023-06-02, Betula, Byggnad 6M, Norrlands universitetssjukhus, Umeå, 13:00 (svensk)
Opponent
Veileder
Tilgjengelig fra: 2023-05-12 Laget: 2023-05-09 Sist oppdatert: 2023-05-10bibliografisk kontrollert

Open Access i DiVA

fulltext(460 kB)229 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 460 kBChecksum SHA-512
7d092ef69e5377cc6c7699319a262a6e84907eaaadf803361e4873a9a0f46096436bfdda1c4cac21b15cfd54b1750e9b8dd7521017542868006f6e06f0464ee1
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Widbom, LovisaSchneede, JørnKarling, PontusHultdin, Johan

Søk i DiVA

Av forfatter/redaktør
Widbom, LovisaSchneede, JørnKarling, PontusHultdin, Johan
Av organisasjonen
I samme tidsskrift
PLOS ONE

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 229 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 461 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf